Cell Source, Inc.
CLCS · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,771 | -$5,321 | -$5,168 | -$5,472 |
| Dep. & Amort. | $0 | $0 | $285,300,000 | $731,502,000 |
| Deferred Tax | $0 | $0 | -$285,300,000 | -$731,502,000 |
| Stock-Based Comp. | $0 | $445 | $78 | $419 |
| Change in WC | $1,761 | $2,218 | $1,564 | $701 |
| Other Non-Cash | $326 | $309 | $388 | $973 |
| Operating Cash Flow | -$2,684 | -$2,348 | -$3,139 | -$3,379 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $834 | $1,627 | $3,296 | $2,283 |
| Stock Issued | $1,792 | $800 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $111 | $520 | -$28 | $944 |
| Financing Cash Flow | $2,737 | $2,147 | $3,268 | $3,227 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $52 | -$200 | $130 | -$152 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22 | $223 | $93 | $245 |
| End Cash | $75 | $22 | $223 | $93 |
| Free Cash Flow | -$2,684 | -$2,348 | -$3,139 | -$3,379 |